To investigate the molecular mechanisms underlying the function of the TGF-β1/SH2B3 axis in lung cancer, we next determined whether and how TGF-β1 modulated JAK2/STAT3 and SHP2/Grb2/PI3K/AKT signaling. The gene discussed is JAK2; the disease is lung carcinoma.